Orforglipron
ATTAIN-CN
Eli Lilly · Phase 3 · Not yet recruiting · Enrollment 192
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Orforglipron
Eli Lilly · Phase 3 · Not yet recruiting · Enrollment 192
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.